Skip to content

Short-course prevention of febrile seizures in children: A Prospective, Multi-Center, and Real-World study

Short-course prevention of febrile seizures in children: A Prospective, Multi-Center, and Real-World study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016975
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-07-05
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile seizures(FS)

Interventions

Diazepam:Oral diazepam at the early stage of fever to prevent febrile seizure, 0.3mg/kg (Max=10 mg), q8h (=3 times in 24h)
Levetiracetam:oral Levetiracetam after the first episode, 15-30mg/(kg.d), bid, for 3-5 days

Sponsors

The Second Affiliated Hospital of Shantou University Medical College (Department of Pediatrics)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1) Aged between 6 months to 5 years; 2) Seizures resulted from fever (Axillary T=38? or rectal T =38.5 degree C); 3) Agreement to follow the protocol for medication and assessment; 4) Inform consent from childrens guardian.

Exclusion criteria

Exclusion criteria: 1. Epilepsy patient with a history of seizure due to infection; 2. With Central Nervous System (CNS) infection; 3. With toxic encephalopathy; 4. With systematic metabolic disorder; 5. With seizure caused by acute poisoning or inherited metabolic disease; 6. With a history of afebrile seizures; 7. Allergy to the drug used in the trail or the ingredients.

Design outcomes

Primary

MeasureTime frame
Febrile seizure recurrence;

Countries

China

Contacts

Public ContactGuangyu Lin

The Second Affiliated Hospital of Shantou University Medical College (Department of Pediatrics)

Lgy0077@163.com+86 13902709868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026